Draft:Sally Susman
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
Sally Susman (born 1961) is an American corporate affairs executive, board director and author. She served as Executive Vice President and Chief Corporate Affairs Officer of pharmaceutical company Pfizer from 2008 until 2026, where she directed the company's communications, government relations, investor relations and corporate responsibility functions and played a role in Pfizer's public communications during the COVID-19 pandemic.[1][2] She is the author of Breaking Through: Communicating to Open Minds, Move Hearts and Change the World (Harvard Business Review Press, 2023).[3] Susman serves on the boards of UL Solutions, FGS Global and Flutter Entertainment, and is a senior advisor to MTS Health Partners.[4][5][6]
Early life and education
[edit]Susman is the daughter of Louis B. Susman, an American lawyer and investment banker who served as United States Ambassador to the United Kingdom under President Barack Obama, and Marjorie Susman. She grew up in St. Louis, Missouri, and earned a Bachelor of Arts in government from Connecticut College, where she delivered the 2023 commencement address, and also studied at the London School of Economics.[1][4]
Career
[edit]Early career in government and business
[edit]Early in her career, Susman worked in Washington, D.C., as a legislative assistant for the United States Senate Committee on Commerce, Science, and Transportation and later as Deputy Assistant Secretary for Legislative and Intergovernmental Affairs at the United States Department of Commerce, focusing on international trade.[1][2][7] She subsequently worked at American Express, where she served as Vice President, European Corporate Affairs and Communications, from 1995 to 2000.[4][1]
Estée Lauder
[edit]Susman later joined The Estée Lauder Companies, where she was Executive Vice President of Global Communications, leading corporate affairs strategy for the company and its brands and serving on its executive committee.[4][1]
Pfizer
[edit]Susman joined Pfizer in 2008.[1][2] She served in senior corporate affairs roles during her tenure, ultimately becoming Executive Vice President and Chief Corporate Affairs Officer. In that position, she oversaw functions including communications, corporate responsibility, global policy, government relations, patient advocacy and investor relations.[1][4] During her tenure, Susman managed communications through several Pfizer chief executive transitions and played a role in the company's communications strategy during the COVID-19 pandemic, including communications surrounding Pfizer's COVID-19 vaccine.[2][8] In 2012, media and advocacy coverage discussed Susman's involvement in Pfizer's international lobbying concerning pharmaceutical patents and pricing and her role as a fundraising bundler for President Obama's re-election campaign.[9] In July 2025, Pfizer chief executive Albert Bourla announced that Susman would leave the company as part of a restructuring in which the corporate affairs function's responsibilities were distributed among other business units.[2][10] Her departure took effect in early 2026 after approximately 18 years at Pfizer.[2] She continues to serve on the board of directors of The Pfizer Foundation.[1]
Post-Pfizer board and advisory roles
[edit]Susman has served as a non-executive director of UL Solutions since May 2022. According to the company's 2026 proxy statement, she serves on its Human Capital and Compensation Committee and Nominating Committee.[4] In 2026, she joined the Global Executive Board of FGS Global as an independent board member.[5] Effective May 2026, she also joined the board of Flutter Entertainment as a non-executive director.[6] She also serves as a senior advisor to MTS Health Partners.[1] Susman previously served as a non-executive director of WPP plc and Equity Office Properties Trust.[11]
Writing
[edit]Susman is the author of Breaking Through: Communicating to Open Minds, Move Hearts and Change the World (Harvard Business Review Press, 2023), a book drawing on her career in corporate communications, including her experience during the COVID-19 vaccine rollout.[3] The book received coverage in publications including Forbes, Børsen and La Presse.[3][12][13] She has written essays and columns for publications including Time and the Harvard Business Review on topics including communication and leadership.[14][15]
Recognition
[edit]Susman has received industry honors and recognition during her career. She received the Matrix Award from New York Women in Communications and was named PRWeek's Best In-House Pro of the Past 20 Years.[1] Forbes included Susman on its lists of influential chief marketing officers and "50 Over 50." She was ranked No. 10 on PRWeek's U.S. Power List in 2024 and was included in PRovoke Media's Influence 100 that year.[16][17] Crain's New York Business named Susman to its 2024 list of Notable LGBTQIA+ Leaders, citing her role in Pfizer's response to the COVID-19 pandemic.[18] She was also named an Aspen Institute Act III Leadership and Legacy Laureate.[19]
Civic and nonprofit involvement
[edit]Susman is a member of the Council on Foreign Relations. She serves on the boards of the New York Public Library and The Church, an arts nonprofit in Sag Harbor, New York, and is associated with the International Rescue Committee, where she has previously served as board co-chair.[1][4]
Personal life
[edit]Susman lives in New York City with her wife, Robin Canter.[1] She has written publicly about her membership in the LGBTQ+ community.[18]
Works
[edit]Susman, Sally (2023). Breaking Through: Communicating to Open Minds, Move Hearts and Change the World. Harvard Business Review Press. ISBN 978-1647823958. {{cite book}}: Check |isbn= value: checksum (help)
References
[edit]- 1 2 3 4 5 6 7 8 9 10 11 12 "About". Sally Susman. Retrieved August 28, 2026.
- 1 2 3 4 5 6 Fried, Ina (July 8, 2025). "Sally Susman departs Pfizer after 18 years". Axios.
- 1 2 3 Baldoni, John (October 3, 2023). "Communicating From The Heart (And The Soul)". Forbes.
- 1 2 3 4 5 6 7 "UL Solutions Inc. Form DEF 14A". U.S. Securities and Exchange Commission. 2026.
- 1 2 "Sally Susman to join FGS Global board, alongside KKR". Axios. March 5, 2026.
- 1 2 "Flutter Entertainment appoints Sally Susman to board of directors". Gaming Intelligence. December 12, 2025.
- ↑ "Sally Susman". The Minor Consult. Stanford Medicine.
- ↑ "Sally Susman helped steer Pfizer through COVID-19. Her advice for leaders? Learn to write — and listen". Business Insider. July 2025.
- ↑ "Who is Sally Susman, and why does she want poor people to pay higher prices for medicines?". Knowledge Ecology International. March 25, 2012.
- ↑ "She helped launch Pfizer's COVID-19 vaccine in the depths of the pandemic. Now, she's planning her next act". Business Insider. July 2025.
- ↑ "Sally Susman: Positions, Relations and Network". MarketScreener.
- ↑ "A Personal Journey in Communication and Public Affairs". Børsen.
- ↑ "Practicing Graceful Communication". La Presse. December 19, 2023.
- ↑ "5 Tips for Writing Meaningful Thank-You Notes". Harvard Business Review. August 2024.
- ↑ "What the Business Community Can Expect from Mayor Zohran Mamdani". Time.
- ↑ "PRWeek Power List 2024: #10 Sally Susman, Pfizer". PRWeek. 2024.
- ↑ "The Influence 100 2024". PRovoke Media. 2024.
- 1 2 "Sally Susman: Notable LGBTQIA+ Leaders 2024". Crain's New York Business. 2024.
- ↑ "Announcing the Act III: Leadership and Legacy Laureates Initiative". Aspen Institute.

LLM-generated pages with certain obvious signs of being machine generated may be deleted without notice.
Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject.
See the advice page on large language models for more information.